SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study — Stella

Home/Schizophrenia Spectrum and Other Psychotic Disorders/

View on ClinicalTrials.gov

Recruiting

Back to Schizophrenia Spectrum and Other Psychotic Disorders trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United Kingdom

South London and Maudsley NHS Foundation Trust, London

Key details

Sponsor

King's College London

Collaborators

South London and Maudsley NHS Foundation Trust, Sussex Partnership NHS Foundation Trust

Enrollment target

~150 participants

Started

October 2024

Primary completion

September 2027

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.